echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The new crown vaccination broke 1.4 billion doses!

    The new crown vaccination broke 1.4 billion doses!

    • Last Update: 2021-07-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The new crown vaccination broke 1.


    Chinanews client, Beijing, July 14 (Reporter Zhang Ni) According to the latest data released by the National Health Commission, as of the 13th, the cumulative number of doses of the new coronavirus vaccine reported in China has exceeded 1.
    4 billion
    .


    At present, many places have begun to deploy minor vaccination work


    Accumulative vaccination exceeded 1.
    4 billion doses!

    Accumulative vaccination exceeded 1.
    4 billion doses!

    According to data from the National Health Commission, as of July 13, 2021, 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps have reported a total of 1402.
    019 million doses of new coronavirus vaccine
    .

    From a local perspective, the vaccination rate is also increasing rapidly
    .

    For example, in Beijing, as of July 13, the city has reported a total of 35.
    816 million doses of new crown virus vaccines, and a total of 18.
    471 million people have been vaccinated
    .

    Among them, 17.
    454 million people completed the entire vaccination.
    The vaccination rate of the city's permanent population aged 18 and above was 94.
    86%, and the vaccination rate was 89.
    64%
    .

    In Hainan, where the population coverage of the new crown virus vaccine ranks among the highest in the country, as of the end of June, the number of people inoculated with two doses of the new crown virus vaccine in Hainan exceeded 6.
    8 million
    .


    The coverage rate of the two-dose vaccine for people over 18 years old reached 88.


    In Guangxi, from the end of December 2020, the new crown virus vaccination was initiated.
    By 8:00 on July 13, 2021, Guangxi has completed a total of 40,447,500 doses, of which 17.
    031,000 people have completed the second dose
    .

    22 new crown vaccines enter clinical trials

    22 new crown vaccines enter clinical trials

    In terms of vaccine and drug research and development, China is also making positive progress
    .

    According to Yuan Lin, Director of the Department of Drug Supervision and Administration of the State Food and Drug Administration recently, the State Food and Drug Administration has approved 22 COVID-19 vaccines with 5 technical routes to enter clinical trials, and approved 4 COVID-19 vaccines with conditions in accordance with laws and regulations, and organized them in accordance with the law.
    The argument agrees to the emergency use of the other three new crown vaccines
    .

    In terms of drug research and development, as of the end of June, the State Food and Drug Administration has urgently approved 25 drugs (excluding vaccines) to carry out clinical trials of therapeutic drugs for new coronary pneumonia and related indications.
    It has also passed special review and approval procedures for emergency approval of the "triple party".
    "Listed
    .

    New crown vaccine for minors in many places will start

    New crown vaccine for minors in many places will start

    Earlier, the National Health Commission stated that the relevant state departments have approved the emergency use of the new coronavirus inactivated vaccine for people aged 3 to 17 years old
    .


    According to the situation of the epidemic, the needs of prevention and control work and the characteristics of relevant populations, experts will be organized to study and formulate specific policies for vaccination for people aged 3 to 17


    Recently, many places have introduced a "timetable" for vaccination of minors
    .

    For example, in Jingzhou, Hubei, the Jingzhou Center for Disease Control and Prevention previously issued "Reminders on the City's New Coronavirus Vaccination in the Near Future"
    .

    According to the document, starting from August 1, Jingzhou will focus on the free inoculation of new coronavirus vaccines for people aged 12-17 and people over 60
    .


    At the same time, the disease control department called on citizens aged 18-59 who have not yet been vaccinated to complete the vaccination as soon as possible before July 31


    Guangxi has also made it clear in the near future that it will carry out the new crown virus vaccination work for people aged 12-17 in three steps according to national deployment
    .

    In the first step, Guangxi will start and complete the first dose of vaccination for people aged 15-17 in July; the second step, in August, will start and complete the first dose of vaccination for people aged 12-14, and complete the task for people aged 15-17.
    The second dose of vaccination task; the third step: before the end of October, complete the whole course of vaccination for people aged 12-17
    .

    In Suzhou, Anhui, the Suzhou City Center for Disease Control and Prevention recently issued a "Letter to the General Public", which mentioned that in accordance with the national and Anhui province's new crown virus vaccination work deployment, the city will launch new crowns for people aged 12-17 from now on.
    Virus vaccination work
    .

    According to the arrangement, Suzhou will start and complete the first dose of vaccination for people aged 15-17 in July; in August, it will start and complete the first dose of vaccination for people aged 12-14, and complete the second dose of vaccination for people aged 15-17; 9 Complete the second dose of vaccination for people aged 12-14 by the end of the month
    .


    While vaccinating people aged 12-17, vaccinating people over 18 years old will be carried out simultaneously, and the whole course of vaccination will be completed by the end of September


    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.